vimarsana.com
Home
Live Updates
Dr Juneko Grilley-Olson Discusses New Findings, Future Directions for Alliance A091902 Trial in Angiosarcoma : comparemela.com
Dr Juneko Grilley-Olson Discusses New Findings, Future Directions for Alliance A091902 Trial in Angiosarcoma
The Alliance A091902 trial is currently investigating paclitaxel with and without nivolumab in patients who are taxane naive and nivolumab plus cabozantinib in taxane-pretreated patients.
Related Keywords
United States ,
Chicago ,
Illinois ,
American ,
Juneko Grilley Olson ,
Duke University School Of Medicine ,
Alliance Network ,
Duke Cancer Institute ,
American Society Of Clinical Oncology ,
Rapid Oral Abstracts Session ,
American Society ,
Clinical Oncology ,
Duke University School ,
Multicenter Randomized Phase ,
Without Nivolumab ,
With Advanced Angiosarcoma ,
comparemela.com © 2020. All Rights Reserved.